Replies to post #571042 on NorthWest Biotherapeutics Inc (NWBO)

[CaptainObvious]

A likely scenario, imo.

[SkyLimit2022]

Poor Man,

Thanks for your post. The topic of Advent and LP is another baseless distraction that’s being waved around, in my view. I wouldn’t waste your time on that. Because you are a long investor, I understand that you want to listen to what people are saying, but a lot of what you’re hearing is just noise.

The value of this cell-based immunotherapy platform technology will be determined by the integrity of the science, and the regulatory process will be the catalyst.

In my opinion, a lot of unsubstantiated negative information about the company has originated from rumors and baseless innuendo published on social media to muddy the reputation of the company and benefit those attempting to short the stock. Rumors are never supported by full-context trustworthy sources.

Additionally, social media is not a safe and reliable source of info about any drug. Verify what you find posted on social media. Consult professionals and seek trustworthy full-context sources.

The JAMA Oncology independent peer review of the murcidencel (DCVax-L) P3 study dispels a lot of the bad-faith disinformation that has been spread online. Licensed independent physicians and qualified skilled statisticians made clear the significance of this landmark study, its design, and its data.

https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/




https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847

https://ceoworld.biz/2022/04/05/top-5-medical-journals-in-the-world-everyone-should-know-about/

[Horseb4CarT]

It’s more complicated in that there have been other time dependent factors. One factor was effecting an anti takeover defense structure. There are probably others related to UK and EU pedigree and who knows the financial tax angles (not my expertise.)